Soterius
Princeton, US · Founded 2018 · Delaware corporation · 1 known investors
Soterius provides drug safety, pharmacovigilance, and medical affairs services to pharmaceutical companies, including case intake and processing, signal detection, aggregate report writing, and compliance technology. It serves top pharma firms globally with safety experts, QPPVs, and Local Safety Managers across 60+ countries.
Founders & leadership
Soterius was founded in 2018 by Suneet Walia.
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2019
▶$1.5MraisedMar 2020 · 7 investors · Other Health CareRule 506(c)
▶$1.5MraisedMar 2020 · 7 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Suneet WaliaExecutive Officer, Director, Promoter
- Sonia A. VeluchamyDirector
- Rakesh DigheDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $15K
- Proceeds to insiders
- $150K
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Soterius do?
- Soterius provides drug safety, pharmacovigilance, and medical affairs services to pharmaceutical companies, including case intake and processing, signal detection, aggregate report writing, and compliance technology. It serves top pharma firms globally with safety experts, QPPVs, and Local Safety Managers across 60+ countries.
- Who founded Soterius?
- Soterius was founded by Suneet Walia in 2018.
- Who are Soterius's investors?
- Soterius's investors include MedTech Actuator.
- How much funding has Soterius raised?
- Soterius has disclosed $1.5M raised across 1 round.
- Where is Soterius headquartered?
- Soterius is headquartered in Princeton, US.